Halozyme Therapeutics in (halo 0.25 03/01/27)
13F holders, Q3 2025 (September 30)17holders +2
5new positions
3sold out
$3.39avg. 13F price*
At the end of Q3 2025, 17 institutions reported holding Halozyme Therapeutics in (halo 0.25 03/01/27) in their 13F filings, up 2 from Q2 2025. 5 opened new positions and 3 sold out. The largest holders were Nomura Holdings Inc. ($37.0M), Angelo Gordon & Co., L.P. ($5.7M) and Sonora Investment Management Group, LLC ($4.4M).
- Company
- Halozyme Therapeutics in (halo 0.25 03/01/27)
- CUSIP
- 40637HAD1
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $6.5M |
| Exits | 3 | $3.2M |
All 13F filers, Q2 2025 → Q3 2025: 6,892,593 shares bought and 3,596,684 shares sold, net +3,295,909 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 17 holders
| Nomura Holdings Inc. | 0.19% | Add +65.0% | 504,057 | $37.0M |
| Angelo Gordon & Co., L.P. | 0.83% | New | 5,000,000 | $5.7M |
| Sonora Investment Management Group, LLC | 0.31% | Reduce -5.1% | 3,822,000 | $4.4M |
| State of Wisconsin Investment Board | 0.01% | Add +50.0% | 3,000,000 | $3.4M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.01% | No change | 2,650,000 | $3.1M |
| Sei Investments Co. | 0.00% | New | 427,000 | $488K |
| Bank of New York Mellon Corp | 0.00% | Reduce -33.3% | 200,000 | $231K |
| Oppenheimer Asset Management Inc. | 0.00% | New | 175,000 | $200K |
| &partners | 0.00% | Reduce -5.1% | 131,000 | $150K |
| Cetera Investment Advisers | 0.00% | Reduce -6.3% | 118,000 | $135K |
| Mariner, LLC | 0.00% | Add +9.3% | 59,000 | $68K |
| Stephens Inc. | 0.00% | New | 53,000 | $61K |
| National Philanthropic Trust | 0.00% | New | 34,000 | $39K |
| Choreo, LLC | 0.00% | No change | 28,000 | $32K |
| Boussard & Gavaudan Investment Management LLP | 0.00% | Reduce -44.6% | 19,500 | $22K |
| MAI Capital Management | 0.00% | No change | 15,000 | $17K |
| Comerica Bank | 0.00% | No change | 10,000 | $11K |
"% of holder's portfolio" is HALOZYME THERAPEUTICS IN (HALO 0.25 03/01/27)'s weight in each manager's 13F, not the share of Halozyme Therapeutics in (halo 0.25 03/01/27) the manager owns.